Tumor Marking

Question 1

Increased levels may indicate liver or testicular cancer.

Answer 1

Alpha Fetoprotein (AFP) Test

Question 2

Levels are elevated in multiple myeloma and chronic lymphocytic leukemia.

Answer 2

Beta-2 Microglobulin (B2M)

Question 3

Present in the urine of patients with bladder cancer.

Answer 3

Bladder Tumor Antigen (BTA)

Question 4

Used for ovarian cancer detection and management.

Answer 4

CA125

Question 5

Levels are measured to determine the stage of breast cancer.

Answer 5

CA15-3

Question 6

Levels are elevated in stomach, colorectal, and pancreatic cancers.

Answer 6

CA19-9

Question 7

Used to monitor breast cancer; especially useful in testing for recurrences.

Answer 7

CA27-29

Question 8

Monitors colorectal cancer when the disease has spread or after treatment to measure the patient’s response.

Answer 8

Carcinoembryonic Antigen (CEA)

Question 9

Used as a screen for choriocarcinoma and testicular and ovarian cancers.

Answer 9

Human Chorionic Gonadotropin (hCG)

Question 10

Used to measure the stage and/or patient’s response to treatment of small cell cancer and neuroblastoma.

Answer 10

Neuron-specific enolase (NSE)

Question 11

Increased levels may be due to benign prostatic hyperplasia/hypertrophy (BPH) or prostate cancer.

Answer 11

Prostate-specific antigen (PSA)

Question 12

A blood test that can detect the possible appearance of a mutated gene that signals the presence of an early-stage cancer.

Answer 12

SEPT9

Question 13

Used to detect the spread of malignant melanoma.

Answer 13

TA-90

Question 14

To test for colon cancer.

Answer 14

Fecal Occult Blood Test (FOBT)

Question 15

To test for cervical and vaginal cancer.

Answer 15

Papanicolaou Test (PAP)